Viela Bio, Inc. (VIE)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Zhengbin (Bing) Yao
Employees:
1 MEDIMMUNE WAY, GAITHERSBURG, MD 20878
240-780-6356

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, which we collectively refer to as autoimmune diseases. Our approach seeks to redefine the treatment of autoimmune diseases by focusing on critical biological pathways shared across multiple indications. We believe that this approach, which targets the underlying molecular pathogenesis of the disease, allows us to develop more precise therapies, identify patients more likely to respond to treatment and pursue multiple indications for each of our product candidates.

Data derived from most recent annual or quarterly report
Market Cap 2.913 Billion Shares Outstanding54.95 Million Avg 30-day Volume 920.823 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue169.6324 Debt to Equity0.0 EBITDA-150.788 Million
Price to Book Value5.2592 Operating Margin-1320.6488 Enterprise Value1.598 Billion
Current Ratio8.455 EPS Growth0.597 Quick Ratio8.102
1 Yr BETA 1.4097 52-week High/Low 0.0 / Profit Margin-1293.0656
Operating Cash Flow Growth-1.0129 Free Cash Flow to Firm (FCFF) TTM -96.766 Million Free Cash Flow to Equity (FCFE) TTM-108.643 Million
Altman Z-Score23.3918
View SEC Filings from VIE instead.

View recent insider trading info

Viela Bio, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding VIE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VIE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2021-03-16 by CAO YANLING
  • 4: filed on 2021-03-16 by RIVERS TYRELL
  • 4: filed on 2021-03-16 by ASTRAZENECA PLC
  • 4: filed on 2021-03-15 by WICKI ANDREAS
  • 4: filed on 2021-03-15 by HU EDWARD
  • 4: filed on 2021-03-15 by BOYU CAPITAL OPPORTUNITIES MASTER FUND
  • 4: filed on 2021-03-15 by CHAN MITCHELL
  • 4: filed on 2021-03-15 by DRAPPA JORN
  • 4: filed on 2021-03-15 by KASTENMAYER JAMES PAUL
  • 4: filed on 2021-03-15 by NOLET CHRIS

    • Events (8k)

  • 8-K: filed on 2021-03-15:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-03-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-02-16:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2021-02-01:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-12-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2020-09-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2020-08-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2020-06-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2020-06-12:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ASTRAZENECA PLC

    ASTRAZENECA UK LTD

    • 10% Owner
    		 No longer subject to file 2021-03-15 0

    RIVERS TYRELL

    • Director
    		 No longer subject to file 2021-03-15 0

    JACQUES RACHELLE SUZANNE

    • Director
    		 No longer subject to file 2021-03-15 0

    NOLET CHRIS

    • Director
    		 No longer subject to file 2021-03-15 0

    KASTENMAYER JAMES PAUL GENERAL COUNSEL

    • Officer
    		 No longer subject to file 2021-03-15 0

    HU EDWARD

    • Director
    		 No longer subject to file 2021-03-13 0

    YAO ZHENGBIN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 No longer subject to file 2021-03-13 0

    WICKI ANDREAS

    • Director
    		 No longer subject to file 2021-03-13 0

    BOUNDLESS MEADOW LTD

    BOYU CAPITAL FUND III, L.P.

    BOYU CAPITAL GENERAL PARTNER III, L.P.

    BOYU CAPITAL GENERAL PARTNER III, LTD.

    BOYU CAPITAL OPPORTUNITIES MASTER FUND

    BOYU CAPITAL INVESTMENT MANAGEMENT LTD

    BOYU CAPITAL GROUP HOLDINGS LTD.

    XYXY HOLDINGS LTD.

    TONG XIAOMENG

    • 10% Owner
    		 No longer subject to file 2021-03-13 0

    RAGATZ WILLIAM SENIOR VP, HEAD OF COMMERCIAL

    • Officer
    		 No longer subject to file 2021-03-13 0

    DRAPPA JORN CHIEF MEDICAL OFFICER

    • Officer
    		 No longer subject to file 2021-03-13 0

    CHAN MITCHELL CHIEF FINANCIAL OFFICER

    • Officer
    		 No longer subject to file 2021-03-13 0

    CAO YANLING

    • Director
    • 10% Owner
    		 No longer subject to file 2021-03-13 0

    REN AARON SEE REMARKS

    • Officer
    		 113,613 2020-11-18 0

    TONG XIAOMENG

    • Director
    • 10% Owner
    		 8,622,353 2020-06-05 0

    BOUNDLESS MEADOW LTD

    • 10% Owner
    		 1,882,353 2019-10-07 0

    ASTRAZENECA PLC

    • 10% Owner
    		 10 2019-10-02 0

    BOUNDLESS MEADOW LTD

    BOYU CAPITAL FUND III, L.P.

    BOYU CAPITAL GENERAL PARTNER III, L.P.

    BOYU CAPITAL GENERAL PARTNER III, LTD.

    BOYU CAPITAL GROUP HOLDINGS LTD.

    XYXY HOLDINGS LTD.

    TONG XIAOMENG

    • 10% Owner
    		 0 2019-10-02 0

    SORIOT PASCAL

    • Director
    		 0 2019-10-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VIELA BIO INC VIE 2021-03-15 22:15:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 21:45:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 21:15:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 20:45:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 20:15:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 19:45:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 19:15:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 18:45:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 18:15:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 17:45:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 17:15:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 16:45:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 16:15:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 15:45:02 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 15:15:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 14:45:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 14:15:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 13:45:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 13:15:03 UTC -0.4559 0.5259 200000
    VIELA BIO INC VIE 2021-03-15 12:45:02 UTC -0.4559 0.5259 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Index Plus All-Cap Fund VIE -10.0 shares, $-380.0 2020-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments